These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 25093504)

  • 1. Methylation profiles reveal distinct subgroup of hepatocellular carcinoma patients with poor prognosis.
    Mah WC; Thurnherr T; Chow PK; Chung AY; Ooi LL; Toh HC; Teh BT; Saunthararajah Y; Lee CG
    PLoS One; 2014; 9(8):e104158. PubMed ID: 25093504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.
    Song MA; Tiirikainen M; Kwee S; Okimoto G; Yu H; Wong LL
    PLoS One; 2013; 8(2):e55761. PubMed ID: 23437062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips.
    Shen J; Wang S; Zhang YJ; Wu HC; Kibriya MG; Jasmine F; Ahsan H; Wu DP; Siegel AB; Remotti H; Santella RM
    Epigenetics; 2013 Jan; 8(1):34-43. PubMed ID: 23208076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
    Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
    Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation of TRIM58 in hepatocellular carcinoma and its potential clinical implication.
    Qiu X; Huang Y; Zhou Y; Zheng F
    Oncol Rep; 2016 Aug; 36(2):811-8. PubMed ID: 27373520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma.
    He H; Chen D; Cui S; Wu G; Piao H; Wang X; Ye P; Jin S
    BMC Med Genomics; 2020 Aug; 13(1):118. PubMed ID: 32831081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
    Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
    Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes.
    Matsushita J; Okamura K; Nakabayashi K; Suzuki T; Horibe Y; Kawai T; Sakurai T; Yamashita S; Higami Y; Ichihara G; Hata K; Nohara K
    BMC Cancer; 2018 Mar; 18(1):317. PubMed ID: 29566670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of genes and pathways, including the CXCL2 axis, altered by DNA methylation in hepatocellular carcinoma.
    Subat S; Mogushi K; Yasen M; Kohda T; Ishikawa Y; Tanaka H
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):675-684. PubMed ID: 30564899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes.
    Matsushita J; Suzuki T; Okamura K; Ichihara G; Nohara K
    Environ Health Prev Med; 2020 Jul; 25(1):31. PubMed ID: 32703154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.
    Lee S; Lee HJ; Kim JH; Lee HS; Jang JJ; Kang GH
    Am J Pathol; 2003 Oct; 163(4):1371-8. PubMed ID: 14507645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.
    Lu CY; Hsieh SY; Lu YJ; Wu CS; Chen LC; Lo SJ; Wu CT; Chou MY; Huang TH; Chang YS
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1057-68. PubMed ID: 19760608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.
    Yu J; Ni M; Xu J; Zhang H; Gao B; Gu J; Chen J; Zhang L; Wu M; Zhen S; Zhu J
    BMC Cancer; 2002 Nov; 2():29. PubMed ID: 12433278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant CpG island hypermethylation and down-regulation of Oct-6 mRNA expression in human hepatocellular carcinoma.
    Sun JZ; Yang XX; Li XH; Xu WW; Wang Y; Zhu W; Li M
    Dig Dis Sci; 2011 Oct; 56(10):3072-7. PubMed ID: 21448695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
    Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of intragenic methylation in the TUSC1 gene as a novel prognostic marker of hepatocellular carcinoma.
    Shimizu D; Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Suenaga M; Inokawa Y; Hishida M; Takano N; Nishikawa Y; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Oncol Rep; 2014 Mar; 31(3):1305-13. PubMed ID: 24366000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue.
    Yasen M; Obulhasim G; Kajino K; Mogushi K; Mizushima H; Tanaka S; Tanaka H; Hino O; Arii S
    Int J Oncol; 2012 Mar; 40(3):789-97. PubMed ID: 22159460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The landscape of DNA methylation in hepatocellular carcinoma.
    Zheng YF; Lu X; Zhang XY; Guan BG
    J Cell Physiol; 2019 Mar; 234(3):2631-2638. PubMed ID: 30145793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors.
    Hernandez-Vargas H; Lambert MP; Le Calvez-Kelm F; Gouysse G; McKay-Chopin S; Tavtigian SV; Scoazec JY; Herceg Z
    PLoS One; 2010 Mar; 5(3):e9749. PubMed ID: 20305825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.